Takeda

HilleVax’s IPO hauls in $200M for clinical test of VLP norovirus vaccine from Takeda
MedCity News
Mon, 05/2/22 - 11:46 am
IPOs
vaccines
HilleVax
Takeda
norovirus
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
BioSpace
Wed, 04/6/22 - 07:37 pm
Takeda
Evozyne
gene therapy
Rare Diseases
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Fierce Biotech
Tue, 04/5/22 - 11:13 am
Takeda
gene therapy
Evozyne
R&D
Return of Takeda’s Parathyroid Hormone Injection Delayed Indefinitely
BioSpace
Tue, 03/22/22 - 11:16 pm
Takeda
parathyroid
hypoparathyroidism
Natpara
FDA
After price deal, Takeda's lung cancer drug Exkivity wins UK green light ahead of J&J rival
Fierce Pharma
Mon, 03/21/22 - 10:33 pm
Takeda
JNJ
Exkivity
non-small cell lung cancer
UK
Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact
Fierce Biotech
Tue, 02/22/22 - 10:46 am
Takeda
biobucks
gene therapy
Code Biotherapeutics
With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda
Endpoints
Fri, 02/11/22 - 10:11 am
Biogen
Vir Biotechnology
GSK
Johanna Friedl-Naderer
Takeda
PhRMA
Takeda taps a doctor turned patient—and spread-the-word artist—for rare disease awareness campaign
Fierce Pharma
Sat, 02/5/22 - 12:02 pm
Takeda
pharma marketing
patients
Rare Diseases
Takeda shunts jewel of Shire takeover to new spinoff Oak Hill
Fierce Biotech
Tue, 02/1/22 - 10:33 am
Takeda
HilleVax
Oak Hill Bio
Shire
M&A
FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic
Fierce Biotech
Thu, 01/13/22 - 10:19 pm
Denali Therapeutics
Takeda
Alzheimer's disease
FDA
DNL919
With Sanofi's mighty Dupixent chasing behind, Takeda's Eohilia suffers FDA rejection after mysterious delay
Fierce Pharma
Wed, 12/22/21 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
FDA
eosinophilic esophagitis
FDA clears Takeda drug for post-transplant CMV infections
Pharmaforum
Wed, 11/24/21 - 10:06 am
Takeda
FDA
post-transplant CMV
Livtencity
maribavir
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf
Fierce Biotech
Wed, 11/10/21 - 10:22 am
Poseida Therapeutics
CAR-T
BCMA
Takeda
Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come
Fierce Pharma
Mon, 11/8/21 - 10:54 am
Takeda
Alunbrig
value-based pricing
drug pricing
lung cancer
Takeda to buy GammaDelta to accelerate allogeneic cell therapies development
Pharmaceutical Business Review
Thu, 10/28/21 - 10:37 am
Takeda
GammaDelta Therapeutics
M&A
allogeneic cells
solid tumors
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform
Fierce Biotech
Fri, 10/22/21 - 12:10 pm
Egle Therapeutics
tregs
Takeda
funding
Takeda, Wave Life Sciences revise their $230M R&D collaboration, dropping discovery work
Endpoints
Tue, 10/19/21 - 10:51 am
Takeda
Wave Life Sciences
R&D
Calithera buys itself a plan B
EP Vantage
Tue, 10/19/21 - 10:43 am
Calithera Biosciences
Takeda
telaglenastat
sapanisertib
mivovatinib
lung cancer
B cell lymphoma
Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft
MedCity News
Thu, 10/14/21 - 11:04 am
Takeda
cell therapy
B cell therapies
Immusoft
R&D
Poseida, Takeda partner to develop eight in vivo gene therapy programs
Pharmaceutical Business Review
Wed, 10/13/21 - 10:51 am
Takeda
Poseida Therapeutics
gene therapy
drug development

Pages